Akebia Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Akebia Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Akebia Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 130 %, a 55.7% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Return On Equity for 2023 was 179 %.
  • Akebia Therapeutics, Inc. annual Return On Equity for 2022 was -397 %, a 111% decline from 2021.
  • Akebia Therapeutics, Inc. annual Return On Equity for 2021 was -188 %, a 62.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 130 -163 -55.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 123 -1.09K -89.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 139 +571 Jan 1, 2024 Mar 31, 2024
Q4 2023 179 +576 Oct 1, 2023 Dec 31, 2023
Q3 2023 293 +679 Jul 1, 2023 Sep 30, 2023
Q2 2023 1.21K +1.43K Apr 1, 2023 Jun 30, 2023
Q1 2023 -432 -162 -59.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -397 -209 -111% Oct 1, 2022 Dec 31, 2022
Q3 2022 -386 -231 -148% Jul 1, 2022 Sep 30, 2022
Q2 2022 -223 -97.4 -77.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -270 -133 -97.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -188 -72.7 -63% Oct 1, 2021 Dec 31, 2021
Q3 2021 -155 -49.6 -46.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -126 -31.2 -33% Apr 1, 2021 Jun 30, 2021
Q1 2021 -137 -76.5 -127% Jan 1, 2021 Mar 31, 2021
Q4 2020 -115 -57.9 -101% Oct 1, 2020 Dec 31, 2020
Q3 2020 -106 -61 -136% Jul 1, 2020 Sep 30, 2020
Q2 2020 -94.8 -48.3 -104% Apr 1, 2020 Jun 30, 2020
Q1 2020 -60.4 -9.36 -18.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -57.5 -7.16 -14.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -44.8 -1.5 -3.46% Jul 1, 2019 Sep 30, 2019
Q2 2019 -46.5 -2.02 -4.54% Apr 1, 2019 Jun 30, 2019
Q1 2019 -51 -6.89 -15.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -50.3 +44.7 +47.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -43.3 +156 +78.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -44.5 +174 +79.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -44.1 +142 +76.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -95 +20.5 +17.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -199 -110 -125% Jul 1, 2017 Sep 30, 2017
Q2 2017 -219 -149 -213% Apr 1, 2017 Jun 30, 2017
Q1 2017 -186 -135 -264% Jan 1, 2017 Mar 31, 2017
Q4 2016 -116 -68.9 -148% Oct 1, 2016 Dec 31, 2016
Q3 2016 -88.4 -46.9 -113% Jul 1, 2016 Sep 30, 2016
Q2 2016 -69.9 -34.3 -96.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -51.1 -16 -45.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -46.6 -14.9 -47% Oct 1, 2015 Dec 31, 2015
Q3 2015 -41.5 +13.8 +24.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -35.6 Apr 1, 2015 Jun 30, 2015
Q1 2015 -35.1 Jan 1, 2015 Mar 31, 2015
Q4 2014 -31.7 Oct 1, 2014 Dec 31, 2014
Q3 2014 -55.3 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.